Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 11, 2020

Total Value ($000): $229,556 (100.0% shares, 0.0% debt)

Holdings (14)

BBIO BridgeBio (BBIO) 50.4%

Value ($000) $115,693 Shares 3,989,412 Est. Cost $27.40 Unrealized +13.1%

— Eidos Therapeutics, Inc. (EIDIX) 24.0%

Value ($000) $55,047 Shares 1,123,630 Est. Cost $13.76 Unrealized —

— AVROBIO, Inc. (AVRO) 6.8%

Value ($000) $15,712 Shares 1,009,779 Est. Cost $16.72 Unrealized —

SNDX Syndax Pharmaceuticals Inc. (SNDX) 4.2%

Value ($000) $9,599 Shares 875,000 Est. Cost $9.38 Unrealized 0.0%

— Atreca (BCEL) 2.8%

Value ($000) $6,416 Shares 387,653 Est. Cost $18.84 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 2.6%

Value ($000) $6,017 Shares 1,291,151 Est. Cost $7.61 Unrealized —

RCUS Arcus Biosciences, Inc. (RCUS) 2.0%

Value ($000) $4,627 Shares 333,333 Est. Cost $11.67 Unrealized +6.5%

— Sunesis Pharmaceuticals, Inc. (SNSS) 1.8%

Value ($000) $4,190 Shares 10,100,000 Est. Cost $0.89 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 1.7%

Value ($000) $3,800 Shares 2,000,000 Est. Cost $5.55 Unrealized —

— ObsEva SA (OBSV) 1.5%

Value ($000) $3,341 Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Verona Pharma plc (VRNA) 0.8%

Value ($000) $1,828 Shares 443,596 Est. Cost $9.65 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.7%

Value ($000) $1,528 Shares 2,718,226 Est. Cost $2.15 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.5%

Value ($000) $1,098 Shares 1,910,287 Est. Cost $1.49 Unrealized —

ACRS Aclaris Theraputics Inc (ACRS) 0.3%

Value ($000) $660 Shares 634,455 Est. Cost $10.31 Unrealized -86.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio (BBIO)	3,989,412	$115,693	50.4%	$27.40	+13.1%	COM	10806X102
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$55,047	24.0%	$13.76	—	COM	28249H104
—	AVROBIO, Inc. (AVRO)	1,009,779	$15,712	6.8%	$16.72	—	COM	05455M100
SNDX	Syndax Pharmaceuticals Inc. (SNDX)	875,000	$9,599	4.2%	$9.38	0.0%	COM	87164F105
—	Atreca (BCEL)	387,653	$6,416	2.8%	$18.84	—	CL A COM	04965G109
—	Aeglea Biotherapeutics Inc (AGLE)	1,291,151	$6,017	2.6%	$7.61	—	COM	00773J103
RCUS	Arcus Biosciences, Inc. (RCUS)	333,333	$4,627	2.0%	$11.67	+6.5%	COM	03969F109
—	Sunesis Pharmaceuticals, Inc. (SNSS)	10,100,000	$4,190	1.8%	$0.89	—	COM	867328700
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$3,800	1.7%	$5.55	—	COM	57055L107
—	ObsEva SA (OBSV)	1,386,338	$3,341	1.5%	$12.66	—	COM	H5861P103
—	Verona Pharma plc (VRNA)	443,596	$1,828	0.8%	$9.65	—	COM	925050106
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$1,528	0.7%	$2.15	—	COM	98979H202
—	Nabriva Therapeutics plc (NBRV)	1,910,287	$1,098	0.5%	$1.49	—	SHS	G63637105
ACRS	Aclaris Theraputics Inc (ACRS)	634,455	$660	0.3%	$10.31	-86.8%	COM	00461U105